Shares of Sanofi-Aventis (NYSE:SNY) traded today at $46.15, breaking its 52-week high. So far today approximately 580,000 shares have been exchanged, as compared to an average 30-day volume of 1.8 million shares.
Over the past year, Sanofi-Aventis has traded in a range of $33.03 to $46.15 and is now at $46.15, 40% above that low. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has risen 0.3%.
Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
Sanofi-Aventis has overhead space with shares priced $46.15, or 9.3% below the average consensus analyst price target of $50.89. The stock should discover initial support at its 50-day moving average (MA) of $43.96 and subsequent support at its 200-day MA of $39.53.